Health Care: Drugs

Opexa Therapeutics Inc (OPXA: NASDAQ)

$1.58 -0.02 | -1.25%
07/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.55
52 Week High 3.70
52 Week Low 1.25
Avg. Daily Vol. (Mil) 0.22
Beta (3 year) 1.39
Share Related Items
Mkt Cap (Mil) 42.88
Shares Out (Mil) 27.66
Float (Mil) 26.87
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.90
Current Ratio 6.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 30.73
Price/Book 2.47
Price/Cash Flow -2.80
Per Share Data
Earnings -0.86
Sales 0.05
Book Value 0.63
Cash Flow -0.55
Business Summary
Opexa Therapeutics, Inc., Opexa Therapeutics, Inc., is engaged in developing personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis. These therapies are based on the proprietary T-cell technology.
General Information
2635 Technology Forest Boule
The Woodlands, TX 77381
www.opexatherapeutics.com
Industry : Drugs
Sector: Health Care
Employees: 38
CEO: Neil K. Warma
Short Interest
Current Month (Mil) 1.00
Previous Month (Mil) 1.04
Short Interest Ratio (Days) 5.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -71.10
Return on Investments -93.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OPXA

Latest OPXA Headlines from TheStreet

More Financial News for OPXA

Press Releases for OPXA

See All Press Releases

Partner Headlines for OPXA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter